Indeed, while recent research indicates that EGF receptor (EGFR) could be a crucial target in treating triple-negative BC, basal-like BC, and inflammatory BC [22], the interplay between EGF and TGF-β signaling has been reported as equally important in PC [23,24]. Here, TGFB1 is linked to breast cancer.